(Q43740421)

26 November 2017

title

Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine (English)

1 reference

26 November 2017

0 references

Coleiro B

1

1 reference

26 November 2017

Marshall SE

2

1 reference

26 November 2017

Denton CP

3

1 reference

26 November 2017

Howell K

4

1 reference

26 November 2017

Blann A

5

1 reference

26 November 2017

Welsh KI

6

1 reference

26 November 2017

Black CM

7

1 reference

26 November 2017

publication date

1 September 2001

1 reference

26 November 2017

1 reference

26 November 2017

volume

40

1 reference

26 November 2017

issue

9

1 reference

26 November 2017

page(s)

1038-1043

1 reference

Pharmacotherapy of Raynaud's phenomenon

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F40.9.1038

Losartan therapy for Raynaud's phenomenon and scleroderma: clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F40.9.1038

Raynaud's disease, Raynaud's phenomenon, and serotonin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F40.9.1038

Treatment of raynaud's phenomenon with ketanserin, a selective antagonist of the serotonin2 (5-HT2) receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F40.9.1038

The endothelium: its role in scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F40.9.1038

Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F40.9.1038

Nifedipine in the treatment of Raynaud's phenomenon in patients with systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F40.9.1038

Serotonergic status in human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F40.9.1038

Determination of serotonin in whole blood, platelet-rich plasma, platelet-poor plasma and plasma ultrafiltrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F40.9.1038

Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F40.9.1038

10.1093/RHEUMATOLOGY/40.9.1038

21 January 2018

Identifiers

DOI

1 reference

release_ejfmz4fqrjgytdmye7cx4whmy4

26 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ejfmz4fqrjgytdmye7cx4whmy4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference